Anavex Life Sciences Corp (AVXL)

[dadofmarcmax]

Proper preparation and planning is the key to success.

When I went to the investors meeting in 2016, I asked Missling about the screening process for any AD trial given my anecdotal experience in clinical Epileptology and general neurology in diagnosing other problems mimicking dementia or as a comorbid condition contributing to multifactorial effects on cognition beyond dementia. At the time, he went on to describe how they were focused on learning everything they could in the early stages in order to properly identify pure AD patients, in order to ensure the highest chance of success in getting a drug to market. This was prior to the shift to the “precision medicine” verbiage in the investor literature that occurred later on.

In 2016; I was impatient but realize now how important it is to go slow, lean and nimble nd learn all you can “on the cheap” before spending on more pivotal late stage expensive trials.

The preparation is mostly completed and the execution has begun, in earnest.

Thank you for the encouraging post at the end of a long day!